Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil D Gross

Showing results (131-140 of 140) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 140 results.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Radiation Oncology (London, England)|November 25, 2017
Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old, Salman A Eraj, Mona K Jomaa, et al.
Radiation Oncology (London, England)|September 11, 2017
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old, Salman A Eraj, Mona K Jomaa, et al.
Research Square|July 28, 2023
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockadeErez N Baruch, Priyadahrshini Nagarajan, Frederico O Gleber-Netto, et al.
Oral Oncology|July 18, 2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311Robert L Ferris, Yael Flamand, F Christopher Holsinger, et al.
Journal of the National Cancer Institute|August 9, 2022
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort StudyJohn C Hardman, F Chris Holsinger, Grainne C Brady, et al.
Lancet (London, England)|December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trialSteven J Frank, Paul M Busse, J Jack Lee, et al.
Head & Neck|April 29, 2020
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic, , Anastasios Maniakas, et al.
Nature|August 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapyErez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan, et al.
Oral Oncology|June 11, 2019
Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approachGioia Di Credico, Valeria Edefonti, Jerry Polesel, et al.
Pageof 14

Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Radiation Oncology (London, England)|November 25, 2017
Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old, Salman A Eraj, Mona K Jomaa, et al.
Radiation Oncology (London, England)|September 11, 2017
Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old, Salman A Eraj, Mona K Jomaa, et al.
Research Square|July 28, 2023
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockadeErez N Baruch, Priyadahrshini Nagarajan, Frederico O Gleber-Netto, et al.
Oral Oncology|July 18, 2020
A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311Robert L Ferris, Yael Flamand, F Christopher Holsinger, et al.
Journal of the National Cancer Institute|August 9, 2022
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort StudyJohn C Hardman, F Chris Holsinger, Grainne C Brady, et al.
Lancet (London, England)|December 14, 2025
Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trialSteven J Frank, Paul M Busse, J Jack Lee, et al.
Head & Neck|April 29, 2020
Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic, , Anastasios Maniakas, et al.
Nature|August 20, 2025
Cancer-induced nerve injury promotes resistance to anti-PD-1 therapyErez N Baruch, Frederico O Gleber-Netto, Priyadharsini Nagarajan, et al.
Oral Oncology|June 11, 2019
Joint effects of intensity and duration of cigarette smoking on the risk of head and neck cancer: A bivariate spline model approachGioia Di Credico, Valeria Edefonti, Jerry Polesel, et al.
Pageof 14